Skip to content

Studying the effects of lit-control Ph up drug on calcium stone excretion

Studying the effects of lit-control Ph up drug on calcium stone excretion: clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20251229068485N1
Enrollment
72
Registered
2026-04-20
Start date
2026-01-20
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with kidney stones. Calculus of kidney

Interventions

Intervention 1: Intervention group: patients with a history of stone passage who currently had small stones in the kidney or ureter were enrolled in the study. After enrollment, participants received

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: People aged 20-50 A history of treated kidney or ureteral stones The presence of stones smaller than 7 mm in size inside the kidney

Exclusion criteria

Exclusion criteria: Comorbidities including gout, primary and secondary hyperparathyroidism, history of parathyroid surgery Chronic use of carbonic anhydrase inhibitors such as acetazolamide and topiramate, loop diuretics Uric acid stones, infectious stones, and struvite stones

Design outcomes

Primary

MeasureTime frame
Excretion of kidney stones. Timepoint: Before the intervention and three months after the start of the intervention. Method of measurement: Ultrasound and patient report.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmin Bagheri

Tabriz University of Medical Sciences

smr_mtn@yahoo.com+98 41 3334 1289

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026